tradingkey.logo

Aptevo soars after billionaire investor discloses stake

ReutersSep 18, 2025 10:56 AM

Shares of drug developer Aptevo Therapeutics APVO.O rise 84% to $2.60 premarket

On Wednesday, co in a filing said that hedge fund billionaire Steven Cohen's firm has taken a 9.1% stake in APVO

Point72 Asset Management, founded by Cohen in 2014, now holds 299,944 shares of Aptevo

The firm has shared voting and dispositive power over the shares

On Tuesday, APVO said its experimental cancer therapy led to 100% remission in an early-to-mid stage trial

As of last close, stock down 98% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI